Every 10-Q that CIMG Inc (IMG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow IMG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMG filings page.
CIMG Inc. filed an amended quarterly report for the quarter ended December 31, 2025 to add a full Management’s Discussion and Analysis section; the underlying financial statements are unchanged.
The company generated revenues of $15,768,796, all from China, versus $22,853 a year earlier, but reported a gross profit of only $87,416 and an operating loss of $1,992,573. A fair value loss of $17,502,596 on Bitcoin holdings drove a net loss attributable to CIMG of $19,443,692, or $1.43 per share. As of December 31, 2025, CIMG held 730 Bitcoin valued at $63,978,821, while cash was $45,356.
Management discloses recurring losses, negative operating cash flow, a working capital deficit of $7,493,110 and states there is substantial doubt about the company’s ability to continue as a going concern without immediate additional financing. During the quarter, CIMG completed a 1‑for‑20 reverse stock split, converted all outstanding convertible notes into equity, and issued new shares via private placements and stock compensation. Subsequent events include a new $5,000,000 convertible note facility, issuance of up to 74,487,896 performance-based shares for an acquisition, a Nasdaq decision to delist the stock for multiple listing rule deficiencies, a charter amendment increasing authorized Common Stock to 2,000,000,000 shares, and a $222,062.28 court judgment in favor of former directors for unpaid fees.
CIMG Inc.$15,768,796, almost entirely from China, driven by its Homology of Medicine and Food, Computing Power, and Maca product series.
Despite positive gross profit, the company posted a net loss of $19,510,872, largely due to a $17,502,596 fair value loss on its Bitcoin holdings. CIMG held 730 Bitcoin valued at $63,978,821 as a non‑current asset, while cash was only $45,356 and working capital was negative by $7,562,771, leading management to state substantial doubt about its ability to continue as a going concern.
Equity increased through large private placements and convertible note conversions, but operations still consumed $8,527,698 of cash in the quarter. Management concluded internal control over financial reporting was not effective, and the company faces a finalized judgment of about $222,062 related to former directors, alongside other ongoing litigation.
CIMG Inc. (IMG) filed an amended quarterly report for the quarter ended March 31, 2025 to add the missing MD&A, market risk, and controls and procedures sections, without changing previously reported financial statements. The company is transitioning from specialty coffee into broader functional beverages in Asia, including its new Maca Series, but revenue has fallen sharply, with six‑month revenue of $22,853 versus $1,289,338 a year earlier.
CIMG reported a net loss of $1,921,805 for the six months ended March 31, 2025, narrower than the prior year’s $3,802,542 loss, helped by $403,635 of other income largely from payables settlement. The balance sheet is strained: cash was only $2,404, inventories jumped to $12,751,596, and management states these factors raise doubt about the ability to continue as a going concern, noting an immediate need to raise capital.
To fund operations, the company issued $10,000,000 of 7% convertible notes in December 2024 that were fully converted into 19,457,618 common shares in March 2025, and it completed a $2,000,000 private placement and a subsequent $1,068,480 private placement for 6,000,000 shares. Warrants outstanding rose to 25,799,900. CIMG also acquired 51% of Beijing Xilin at a loss on acquisition and later closed on 51% of Shanghai Huomao. The company received a Nasdaq delisting determination after failing to timely file its Form 10‑K for the year ended September 30, 2024 and plans to appeal and regain compliance. As of September 17, 2025, there were 188,180,751 common shares outstanding.
CIMG Inc. filed an amended quarterly report for the quarter ended December 31, 2024 to add previously omitted MD&A, market risk, and controls and procedures disclosures, without changing its financial statements. The company is shifting from specialty coffee into Asia-focused functional food and beverage products, led by a new maca-based product line that replaced its legacy single-serve coffee business.
Quarterly revenue fell sharply to $22,853 from $965,932 a year earlier as coffee sales ceased, while net loss narrowed to $1,536,249 from $2,148,611 due to lower operating expenses. Gross margin improved to 67.73% on the new products, but cash was only $124,715 and inventories were $4,608,307, leaving the business reliant on external financing.
Subsequent private placements raised $10,000,000 in convertible notes (19,457,618 shares issued on conversion) and $1,068,480 for 6,000,000 shares, meaning significant equity issuance. CIMG faces Nasdaq notices for minimum bid price and late SEC filings and has received a delisting determination after missing its Form 10-K deadline, which it plans to appeal. The company also reports ongoing litigation with an investor and former directors after settling a prior employment case.
CIMG Inc. (IMG) filed Amendment No. 1 to its Quarterly Report for the quarter ended June 30, 2025, adding Management’s Discussion and Analysis and Items 3 and 4; no other disclosures or financial statements were modified. New CEO/CFO certifications are included.
For Q3 2025, revenue was $61,578 (vs. $366,888 a year ago) and net loss was $1,068,242. For the nine months, revenue totaled $84,431 (vs. $1,641,955) with a net loss of $2,990,047. The company reported cash of $35,958 and working capital of $10,571,104 as of June 30, 2025, and stated it will need to raise additional capital immediately to fund operations, preparing the statements on a going concern basis.
Balance sheet highlights include inventories of $11,882,544, shareholders’ equity of $10,637,317, and 36,397,418 shares outstanding as of June 30, 2025. Financing activities in the period included $10,000,000 from an ATM program and a June 2, 2025 private placement of 6,000,000 shares for $1,068,480. Warrants totaling 25,798,750 were outstanding at quarter end.
Subsequent items note a default judgment of $58,920.34 in an ex-directors fee dispute with potential amendment pending, and a previously disclosed employment matter settled for $125,000 and dismissed. A preliminary injunction motion in separate litigation was denied on February 13, 2025.
CIMG Inc. (IMG) filed its June 30, 2025 quarterly report, showing a much smaller business after strategic shifts. Q3 revenue was $61,578 and the quarter’s net loss was $1,068,242. For the nine months, revenue totaled $84,431 with a net loss of $2,990,047. The company ended the period with cash of $35,958 and working capital of $10,571,104, and stated it anticipates needing to raise additional capital immediately. Total liabilities fell to $2,671,985 from $6,238,323, while stockholders’ equity improved to $10,637,317.
Results reflect a transition from North America to China, with nine‑month revenue of $84,431 generated in the P.R.C. only. Inventory rose to $11,882,544 as of June 30, 2025. During the period, CIMG acquired 51% interests in Beijing Xilin and Huomao for no consideration, recording small losses on acquisition. Financing activities provided $10,964,632, including an at‑the‑market common stock issuance of $10,000,000 and private placements. Subsequent events include large unregistered issuances and a convertible note conversion. As of October 27, 2025, there were 196,514,084 common shares outstanding.
CIMG Inc. reported continued operating losses, limited cash and significant equity financings that materially changed its capital structure. The company recorded net losses reflected in basic and diluted loss per share of $(0.03) and $(1.28) for the recent periods and reported no cash equivalents for the three and six months ended March 31, 2025 and 2024. Management completed conversions and issuances of convertible notes and warrants, including a conversion completed October 31, 2024, and subsequent issuance of 6,000,000 shares for $1,068,480 in June 2025. The company disclosed a going concern qualification citing working capital of $10,537,508 and related uncertainties. Significant non‑cash items include loss on acquisition (51% proportionate share recorded) and foreign currency translation losses of $(254,555) for six months. Lease ROU assets and liabilities and related short‑term lease disclosures were presented, and contingencies include ongoing litigation with discovery pending.